Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4545641019 | Product containing only rilpivirine in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4545642014 | Rilpivirine only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing only rilpivirine in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
Product containing only rilpivirine in parenteral dose form (medicinal product form) | Plays role | Antiretroviral therapeutic role | true | Inferred relationship | Some | ||
Product containing only rilpivirine in parenteral dose form (medicinal product form) | Is a | Product containing only rilpivirine (medicinal product) | true | Inferred relationship | Some | ||
Product containing only rilpivirine in parenteral dose form (medicinal product form) | Is a | Rilpivirine-containing product in parenteral dose form | true | Inferred relationship | Some | ||
Product containing only rilpivirine in parenteral dose form (medicinal product form) | Has active ingredient | Rilpivirine | true | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Rilpivirine 300 mg/mL prolonged-release suspension for injection | Is a | True | Product containing only rilpivirine in parenteral dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets